Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naïve patients: A retrospective cohort study
BMC Urology Jun 02, 2018
Washino S, et al. - Researchers ascertained if prebiopsy multiparametric magnetic resonance imaging (mpMRI) with subsequent systematic plus targeted biopsies for suspicious lesions improved prostate cancer detection vs standard non-targeting systematic biopsies without mpMRI in biopsy-naive patients. A higher cancer detection rate could be yielded by prebiopsy mpMRI with subsequent systematic plus targeted biopsies for suspicious lesions than non-targeting systematic biopsies. For predicting the biopsy outcome, Prostate Imaging Reporting and Data System ver. 2 (PIRADS-2) scoring was useful.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries